Jump to ContentJump to Main Navigation

Cellular and Molecular Biology Letters

Editor-in-Chief: /

4 Issues per year


Impact Factor 2014: 1.593
5-year IMPACT FACTOR: 1.647

SCImago Journal Rank (SJR): 0.673
Source Normalized Impact per Paper (SNIP): 0.530

VolumeIssuePage

Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression

1Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania, Silverstein 4, 3400 Spruce St., Philadelphia, PA, 19104, USA

© 2006 University of Wrocław, Poland. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Citation Information: Cellular and Molecular Biology Letters. Volume 12, Issue 1, Pages 127–138, ISSN (Online) 1689-1392, DOI: 10.2478/s11658-006-0058-7, November 2006

Publication History

Published Online:
2006-11-19

Abstract

Apelin interacts with the APJ receptor to enhance inotropy. In heart failure, apelin-APJ coupling may provide a means of enhancing myocardial function. The alterations in apelin and APJ receptor concentrations with ischemic cardiomyopathy are poorly understood. We investigated the compensatory changes in endogenous apelin and APJ levels in the setting of ischemic cardiomyopathy.

Male, Lewis rats underwent LAD ligation and progressed into heart failure over 6 weeks. Corresponding animals underwent sham thoracotomy as control. Six weeks after initial surgery, the animals underwent hemodynamic functional analysis in the presence of exogenous apelin-13 infusion and the hearts were explanted for western blot and enzyme immunoassay analysis.

Western blot analysis of myocardial APJ concentration demonstrated increased APJ receptor protein levels with heart failure (1890750±133500 vs. 901600±143120 intensity units, n=8, p=0.00001). Total apelin protein levels increased with ischemic heart failure as demonstrated by enzyme immunoassay (12.0±4.6 vs. 1.0±1.2 ng/ml, n=5, p=0.006) and western blot (1579400±477733 vs. 943000±157600 intensity units, n=10, p=0.008). Infusion of apelin-13 significantly enhanced myocardial function in sham and failing hearts. We conclude that total myocardial apelin and APJ receptor levels increase in compensation for ischemic cardiomyopathy.

Keywords: Apelin; G protein coupled receptor; APJ; Inotrope

  • [1] O’Dowd, B.F., Heiber M., Chan, A., Heng, H.H.Q., Tsui, L.C., Kennedy, J.L., Shi, X., Petronis, A., George, S.R. and Nguyen, T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 (1993) 355–360. http://dx.doi.org/10.1016/0378-1119(93)90495-O

  • [2] Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., Kurokawa, T., Onda, H., and Fujino, M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251 (1998) 471–476. http://dx.doi.org/10.1006/bbrc.1998.9489 [CrossRef]

  • [3] Habata, Y., Fujii, R., Hosoya, M., Fukusumi, S., Kawamata, Y., Hinuma, S., Kitada, C., Nishizawa, N., Murosaki, S., Kurokawa, T., Onda, H., Tatemoto, K. and Fujino, M. Apelin the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrums. Biochim. Biophys. Acta 1452 (1999) 25–35. http://dx.doi.org/10.1016/S0167-4889(99)00114-7 [CrossRef]

  • [4] Kawamata, Y., Habata, Y., Fukusumi, S., Hosoya, M., Fujii, R., Hinuma, S., Nishizawa, N., Kitada, C., Onda, H., Nishimura, O. and Fujino, M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim. Biophys. Acta 1538 (2001) 162–171. http://dx.doi.org/10.1016/S0167-4889(00)00143-9 [CrossRef]

  • [5] Medhurst, A.D., Jennings, C.A., Robbins, M.J., Davis, R.P., Ellis, C., Winborn, K.Y., Lawrie, K.W.M., Hervieu, G., Riley, G., Bolaky, J.E., Herrity, N.C., Murdock, P. and Darker, J.G. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J. Neurochem. 84 (2003) 1162–1172. http://dx.doi.org/10.1046/j.1471-4159.2003.01587.x [CrossRef]

  • [6] Lee, D.K., Saldivia, V.R., Nguyen, T., Cheng, R., George, S.R., and O’Dowd, B.F. Modification of the terminal residue of apelin-13 antagonises its hypotensive action. Endocrinology 146 (2005) 231–236. http://dx.doi.org/10.1210/en.2004-0359 [CrossRef]

  • [7] Lee, D.K., Lanca, A.J., Cheng, R., Nguyen, T., Ji, X.D., Gobeil, F., Chemtob, S., George, S.R., and O’Dowd, B.F. Agonist-independent nuclear localization of the apelin, angiotenesin AT1, and bradykinin B2 receptors. J. Biol. Chem. 279 (2004) 7901–7908. http://dx.doi.org/10.1074/jbc.M306377200 [CrossRef]

  • [8] Hosoya, M., Kawamata, Y., Fukusumi, S., Fuji, R., Habata, Y., Hinuma, S., Kitada, C., Honda, S., Kurokawa, T., Onda, H., Nishimura, O. and Fujino, M. Molecular and functional characteristics of APJ — tissue distribution of mRNA and interaction with the endogenous ligand apelin. J. Biol. Chem. 275 (2000) 21061–21067. http://dx.doi.org/10.1074/jbc.M908417199 [CrossRef]

  • [9] Lee, D.K., Cheng. R., Nguyen, T., Fan, T., Kariyawasam, A.P., Liu, Y., Osmond, D.H., George, S.R., and O’Dowd, B.F. Characterization of apelin, the ligand for the APJ receptor. J. Neurochem. 74 (2000) 34–41. http://dx.doi.org/10.1046/j.1471-4159.2000.0740034.x [CrossRef]

  • [10] O’Carroll, A.M. and Lolait, S.J. Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurons of the paraventricular and supraopric nuclei by osmotic stimuli. J. Neuroendocrinol. 15 (2003) 661–666. http://dx.doi.org/10.1046/j.1365-2826.2003.01044.x [CrossRef]

  • [11] Sunter, D., Hewson, A.K. and Dickson, S.L. sIntracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci. Lett. 353 (2003) 1–4s. http://dx.doi.org/10.1016/S0304-3940(03)00351-3 [CrossRef]

  • [12] Horiuchi, Y., Fujii, T., Kamimura, Y. and Kawashima, K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity duringimmunological responses. J. Neuroimmunol. 144 (2003) 46–52. http://dx.doi.org/10.1016/j.jneuroim.2003.08.029 [CrossRef]

  • [13] Szokodi, I., Tavi, P., Voutilainen-Myllyla, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysa, J., Toth, M. and Ruskaoho, H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ. Res. 91 (2002) 434–440. http://dx.doi.org/10.1161/01.RES.0000033522.37861.69 [CrossRef]

  • [14] Ashley, E.A., Powers, J., Chen, M., Kundu, R., Finsterbach, T., Caffarelli, A., Deng, A., Eichorn, J., Mahajan, R., Agrawal, R., Greve, J., Robbins, R., Patterson, A.J., Bernstein, D. and Quertermous, T. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in ivo. Cardiovasc. Res. 65 (2004) 73–82. http://dx.doi.org/10.1016/j.cardiores.2004.08.018 [CrossRef]

  • [15] Berry, M.F., Pirolli, T.J., Jayasankar, V., Burdick, J., Morine, K.J., Gardner, T.J. and Woo YJ. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 Suppl. II (2004) II187–II193.

  • [16] Chen, M.M., Ashley, E.A., Deng, D.X.F., Tsalenko, A., Deng, A., Tabibiazar, R., Ben-Dor, A., Fenster, B., Yang, E., King, J.Y., Fowler, M., Robbins, R., Johnson, F.L., Bruhn, L., McDonagh, T., Dargie, H., Yakhini, Z., Tsao, P.S. and Quertermous, T. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 (2003) 1432–1439. http://dx.doi.org/10.1161/01.CIR.0000091235.94914.75 [CrossRef]

  • [17] Foldes, G., Horkay, F., Szokodi, I., Vuolteenaho, O., Iilves, M., Lindstedt, K.A., Mayranpaa, sM., Sarman, B., Seres, L., Skoumal, R., Lako-Futo, Z., deChatel, R., Ruskoaho, H. and Toth, M. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem. Biophys. Res. Commun. 308 (2003) 480–485. http://dx.doi.org/10.1016/S0006-291X(03)01424-4 [CrossRef]

  • [18] Jayasankar, V., Woo, Y.J., Bish, L.T., Pirolli, T.J., Chatterjee, S., Berry, M.F., Burdick, J., Gardner, T.J. and Sweeney, H.L. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108 Suppl. 1 (2003) II230–6.

  • [19] Woo, Y.J., Grand, T.J., Berry, M.F., Atluri, P., Moise, M.A., Hsu, V., Cohen, J., Fisher, O., Pirolli, T., Burdick, J., Taylor, M., Zentko, S., Jayasankar, V., Gardner, T.J. and Sweeney, H.L. Stromal cell-derived factor and granulocyte monocyte colony stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J. Thoracic. Cardiovasc. Surg. 130 (2005) 321–329. http://dx.doi.org/10.1016/j.jtcvs.2004.11.041 [CrossRef]

  • [20] Liu, Y.H., Yang, X.P., Nass, O., Sabbah, H.B., Peterson, E. and Carretero, O.A. Chronic heart failure induced coronary artery ligation in Lewis inbred rats. Am. J. Physiol. 272 (1997) H722–H727.

  • [21] Cingolani, O.H., Yang, X.P., Liu, Y.H., Villanueva, M., Rhaleb, N.E. and Carretero, O.A. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats. Hypertension 43 (2004) 1067–1073. http://dx.doi.org/10.1161/01.HYP.0000125013.22494.c5 [CrossRef]

  • [22] Tatemoto, K., Takayama, K., Zou, M., Kumaki, I., Zhang, W., Kumano, K. and Fujimiya, M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul. Pept. 99 (2001) 87–92. http://dx.doi.org/10.1016/S0167-0115(01)00236-1 [CrossRef]

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Oleg I. Pisarenko, Valentin S. Shulzhenko, Yulia A. Pelogeykina, Irina M. Studneva, and Denis N. Khatri
Health, 2010, Volume 02, Number 08, Page 927
[2]
Jonathan R. Dalzell, John P. Rocchiccioli, Robin A.P. Weir, Colette E. Jackson, Neal Padmanabhan, Roy S. Gardner, Mark C. Petrie, and John J.V. McMurray
Journal of Cardiac Failure, 2015, Volume 21, Number 6, Page 489
[3]
I. Castan-Laurell, M. Vitkova, D. Daviaud, C. Dray, M. Kovacikova, Z. Kovacova, J. Hejnova, V. Stich, and P. Valet
European Journal of Endocrinology, 2008, Volume 158, Number 6, Page 905
[4]
Badrinathan Chandrasekaran, Owais Dar, and Theresa McDonagh
European Journal of Heart Failure, 2008, Volume 10, Number 8, Page 725
[5]
A.-M. O'Carroll, S. J. Lolait, L. E. Harris, and G. R. Pope
Journal of Endocrinology, 2013, Volume 219, Number 1, Page R13
[6]
Hiromi Inuzuka, Haruki Nishizawa, Ayaka Inagaki, Machiko Suzuki, Sayuri Ota, Hironori Miyamura, Jun Miyazaki, Takao Sekiya, Hiroki Kurahashi, and Yasuhiro Udagawa
Hypertension in Pregnancy, 2013, Volume 32, Number 4, Page 410
[7]
Mengjun Wang, Ramesh C. Gupta, Sharad Rastogi, Smita Kohli, Michael S. Sabbah, Kefei Zhang, Paula Mohyi, Manuela Hogie, Yvan Fischer, and Hani N. Sabbah
Journal of Cardiac Failure, 2013, Volume 19, Number 7, Page 509
[8]
Mi-Hye Kwon, Buyankhuu Tuvshintur, Woo Jean Kim, Hai-Rong Jin, Guo Nan Yin, Kang-Moon Song, Min Ji Choi, Ki-Dong Kwon, Dulguun Batbold, Ji-Kan Ryu, and Jun-Kyu Suh
The Journal of Sexual Medicine, 2013, Volume 10, Number 12, Page 2928
[9]
H. S. Mattu and H. S. Randeva
Journal of Endocrinology, 2013, Volume 216, Number 1, Page T17
[10]
H. Kidoya and N. Takakura
Journal of Biochemistry, 2012, Volume 152, Number 2, Page 125
[11]
Seyyed M. R. Kazemi-Bajestani, Vaibhav B. Patel, Wang Wang, and Gavin Y. Oudit
Cardiology Research and Practice, 2012, Volume 2012, Page 1
[12]
Xiu-Juan Fan and Jun Ren
Cardiovascular Toxicology, 2012, Volume 12, Number 4, Page 275
[13]
Sarah L Pitkin, Janet J Maguire, Rhoda E Kuc, and Anthony P Davenport
British Journal of Pharmacology, 2010, Volume 160, Number 7, Page 1785
[14]
Alan G. Japp and David E. Newby
Biochemical Pharmacology, 2008, Volume 75, Number 10, Page 1882
[15]
Agnieszka M. Tycinska, Anna Lisowska, Wlodzimierz J. Musial, and Bozena Sobkowicz
Clinica Chimica Acta, 2012, Volume 413, Number 3-4, Page 406
[16]
Matthias J. Kleinz and Gary F. Baxter
Regulatory Peptides, 2008, Volume 146, Number 1-3, Page 271
[17]
Caroline Chamberland, Hector Barajas-Martinez, Volker Haufe, Marie-Hélène Fecteau, Jean-Francois Delabre, Alexander Burashnikov, Charles Antzelevitch, Olivier Lesur, Ahmed Chraibi, Philippe Sarret, and Robert Dumaine
Journal of Molecular and Cellular Cardiology, 2010, Volume 48, Number 4, Page 694
[18]
Oreste Gualillo, José Ramón González-Juanatey, and Francisca Lago
Trends in Cardiovascular Medicine, 2007, Volume 17, Number 8, Page 275
[19]
C.U. Andersen, L.H. Markvardsen, O. Hilberg, and U. Simonsen
Respiratory Medicine, 2009, Volume 103, Number 11, Page 1663
[20]
Christopher J Charles
Expert Opinion on Drug Discovery, 2011, Volume 6, Number 6, Page 633
[21]
Zhaoxia Wang and Tomohiro Nakayama
Mediators of Inflammation, 2010, Volume 2010, Page 1
[22]
Jolanta Malyszko, Piotr Kozminski, Jacek Malyszko, and Michal Mysliwiec
International Urology and Nephrology, 2011, Volume 43, Number 1, Page 185
[23]
Raffaella Rastaldo, Sandra Cappello, Anna Folino, and Gianni Losano
Antioxidants & Redox Signaling, 2011, Volume 14, Number 5, Page 909
[24]
Kwok S Chong, Roy S Gardner, Euan A Ashley, Henry J Dargie, and Theresa A McDonagh
Biomarkers in Medicine, 2007, Volume 1, Number 1, Page 37
[25]
Agnieszka M. Kuklinska, Bozena Sobkowicz, Robert Sawicki, Wlodzimierz J. Musial, Ewa Waszkiewicz, Swietlana Bolinska, and Jolanta Małyszko
Heart and Vessels, 2010, Volume 25, Number 5, Page 363
[26]
Robin Quazi, Chandrasekar Palaniswamy, and William H. Frishman
Cardiology in Review, 2009, Volume 17, Number 6, Page 283
[27]
Susan E. Wozniak, Laura L. Gee, Mitchell S. Wachtel, and Eldo E. Frezza
Digestive Diseases and Sciences, 2009, Volume 54, Number 9, Page 1847
[28]
Hyung J. Chun, Ziad A. Ali, Yoko Kojima, Ramendra K. Kundu, Ahmad Y. Sheikh, Rani Agrawal, Lixin Zheng, Nicholas J. Leeper, Nathan E. Pearl, Andrew J. Patterson, Joshua P. Anderson, Philip S. Tsao, Michael J. Lenardo, Euan A. Ashley, and Thomas Quertermous
Journal of Clinical Investigation, 2008
[29]
CJ Charles
Expert Opinion on Drug Discovery, 2008, Volume 3, Number 1, Page 51
[30]
Gopal KR Soppa, Paul JR Barton, Cesare MN Terracciano, and Magdi H Yacoub
Current Opinion in Cardiology, 2008, Volume 23, Number 3, Page 206

Comments (0)

Please log in or register to comment.